Recalcitrant pharmaceuticals in the aquatic environment: A comparative screening study of their occurrence, formation of phototransformation products and their in vitro toxicity

Environmental Chemistry

Volumn 11, Issue 4, 2014, Pages 431-444

  Bergheim, Marlies ^a,b   Gminski, Richard ^a   Spangenberg, Bernd ^c   Dȩbiak, Malgorzata ^d   Bürkle, Alexander ^d   Mersch Sundermann, Volker ^a   Kümmerer, Klaus ^a,e   Gieré, Reto ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c OFFENBURG UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d UNIVERSITY OF KONSTANZ   (Germany)

^e LEUPHANA UNIVERSITY OF LÜNEBURG   (Germany)

Author keywords

Biodegradation; HeLa cells; Hep G2 cells; Irradiation; Predicted environmental concentrations (PECs); UV; Vibrio fischeri

Indexed keywords

EID: 84906669875     PISSN: 14482517     EISSN: 14498979     Source Type: Journal    
DOI: 10.1071/EN13218     Document Type: Article

References (60)

1. T. Heberer, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131, 5. doi:10.1016/S0378-4274(02)00041-3
2. A Comprehensive Literature Review: Monitoring Data on the Occurrence of Pharmaceuticals in the Environment from the German Federal Environmental Agency (UBA) 2011 (German Federal Environmental Agency: Dessau-Rosßlau).
3. R. Loos, B. M. Gawlik, G. Locoro, E. Rimaviciute, S. Contini, G. Bidoglio, EU-wide survey of polar organic persistent pollutants in European river waters. Environ. Pollut. 2009, 157, 561. doi:10.1016/J.ENVPOL.2008.09.020
4. P. Bottoni, S. Caroli, A. Caracciolo, Pharmaceuticals as priority water contaminants. Toxicol. Environ. Chem. 2010, 92, 549. doi:10.1080/ 02772241003614320
5. J. B. Quintana, S. Weiss, T. Reemtsma, Pathway's and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005, 39, 2654. doi:10.1016/J.WATRES. 2005.04.068
6. C. Zwiener, S. Seeger, T. Glauner, F. H. Frimmel, Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal. Bioanal. Chem. 2002, 372, 569. doi:10.1007/S00216-001- 1210-X
7. M. Addamo, V. Augugliaro, A. Di Paola, E. Garcia-Lopez, V. Loddo, G. Marci, L. Palmisano, Removal of drugs in aqueous systems by photoassisted degradation. J. Appl. Electrochem. 2005, 35, 765. doi:10.1007/S10800-005-1630-Y
8. A. L. Boreen, W. A. Arnold, K. McNeill, Photochemical fate of sulfa drugs in the aquatic environment: sulfa drugs containing fivemembered heterocyclic groups. Environ. Sci. Technol. 2004, 38, 3933. doi:10.1021/ES0353053
9. R. Skibiński, Identification of photodegradation product of amisulpride by ultra-high-pressure liquid chromatography-DAD/ESIquadrupole time-of-flight-mass spectrometry. J. Pharmaceut. Biomed. 2011, 56, 904. doi:10.1016/J.JPBA.2011.07.030
10. C. Sirtori, A. Aguera, W. Gernjak, S. Malato, Effect of water-matrix composition on Trimethoprim solar photodegradation kinetics and pathways. Water Res. 2010, 44, 2735. doi:10.1016/J.WATRES.2010. 02.006
11. S. K. Khetan, T. J. Collins, Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem. Rev. 2007, 107, 2319. doi:10.1021/CR020441W
12. W. d. Püttmann, F. Keil, J. Oehlmann, U. Schulte-Oehlmann, Strategy to reduce pharmaceuticals in drinking water - technical approach. Wassertechnische Strategien zur Reduzierung der Trinkwasserbehandlung durch Arzneimittelwirkstoffe 2008, 20, 209.
13. M. J. Gómez,C. Sirtori,M. Mezcua,A.R. Fernández-Alba, A. Agüera, Photodegradation study of three dipyrone metabolites in various water systems: identification and toxicity of their photodegradation products. Water Res. 2008, 42, 2698. doi:10.1016/J.WATRES.2008.01.022
14. M. Isidori, A. Parrella, P. Pistillo, F. Temussi, Effects of ranitidine and its photoderivatives in the aquatic environment. Environ. Int. 2009, 35, 821. doi:10.1016/J.ENVINT.2008.12.002
15. Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use 2006 (European Medical Agency: Brussels).
16. M. Bergheim, R. Gieré, K. Kümmerer, Biodegradability and ecotoxicity of tramadol, ranitidine, and their photoderivatives in the aquatic environment. Environ. Sci. Pollut. R. 2012, 19, 72. doi:10.1007/S11356-011-0536- Y
17. U. Schwabe, D. Paffrath, Pharmaceutical Prescriptions in Germany 2011 2010 (Springer: Berlin).
18. A. Seigel, A. Schroeck, R. Hauser, B. Spangenberg, Sensitive quantification of Diclofenac and Ibuprofen using thin layer chromatography coupled with a Vibrio fisheri bioluminescence Assay. J. Liq. Chromatogr. R. T. 2011, 34, 817. doi:10.1080/10826076.2011.571149
19. G. Repetto, A. del Peso, J. L. Zurita, Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat. Protoc. 2008, 3, 1125. doi:10.1038/NPROT.2008.75
20. M. Moreno-Villanueva, R. Pfeiffer, T. Sindlinger, A. Leake, M. Müller, T. B. Kirkwood, A. Bürkle, A modified and automated version of the 'fluorimetric detection of alkaline DNA unwinding' method to quantify formation and repair of DNA strand breaks. BMC Biotechnol. 2009, 9, 39. doi:10.1186/1472-6750-9-39
21. M. Moreno-Villanueva, T. Eltze, D. Dressler, J. Bernhardt, C. Hirsch, P. Wick, G. von Scheven, K. Lex, A. Bürkle, The automated FADUassay, a potential high-throughput in vitro method for early screening ofDNAbreakage. ALTEX 2011, 28, 295. doi:10.14573/ALTEX.2011. 4.295
22. M. Dȩbiak, A. Panas, D. Steinritz, K. Kehe, A. Bürkle, Highthroughput analysis of DNA interstrand crosslinks in human peripheral blood mononuclear cells by automated reverse FADU assay. Toxicology 2011, 280, 53. doi:10.1016/J.TOX.2010.11.007
23. J. Durner, M. Dȩbiak, A. Bürkle, R. Hickel, F.-X. Reichl, Induction of DNA strand breaks by dental composite components compared to X-ray exposure in human gingival fibroblasts. Arch. Toxicol. 2011, 85, 143. doi:10.1007/S00204-010-0558-0
24. M. Gros, M. Petrovic, D. Barcelo, Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal. Chem. 2009, 81, 898. doi:10.1021/AC801358E
25. N. M. Vieno, H. Harkki, T. Tuhkanen, L. Kronberg, Occurrence of pharmaceuticals in river water and their elimination a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007, 41, 5077. doi:10.1021/ES062720X
26. A. Y. C. Lin, T. H. Yu, C. F. Lin, Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. Chemosphere 2008, 74, 131. doi:10.1016/J.CHEMOSPHERE. 2008.08.027
27. D. Fatta-Kassinos, M. I. Vasquez, K. Kümmerer, Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes - degradation, elucidation of byproducts and assessment of their biological potency. Chemosphere 2011, 85, 693. doi:10.1016/J.CHEMOSPHERE.2011. 06.082
28. M. DellaGreca, M. R. Lesce, M. Isidori, S. Montanaro, L. Previtera, M. Rubino, Phototransformation of amlodipine in aqueous solution: toxicity of the drug and its photoproduct on aquatic organisms. Int. J. Photoenergy 2007, 2007, 63 459. doi:10.1155/2007/63459
29. D. M. Leech, M. T. Snyder, R. G. Wetzel, Natural organic matter and sunlight accelerate the degradation of 17 beta-estradiol in water. Sci. Total Environ. 2009, 407, 2087. doi:10.1016/J.SCITOTENV.2008. 11.018
30. D. E. Latch, B. L. Stender, J. L. Packer, W. A. Arnold, K. McNeill, Photochemical fate of pharmaceuticals in the environment: cimetidine and ranitidine. Environ. Sci. Technol. 2003, 37, 3342. doi:10.1021/ES0340782
31. Y. Kim, K. Choi, J. Jung, S. Park, P. G. Kim, J. Park, Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ. Int. 2007, 33, 370. doi:10.1016/J.ENVINT.2006.11.017
32. R. M. Bianchini, P. M. Castellano, T. S. Kaufman, Characterization of two new potential impurities of Valsartan obtained under photodegradation stress condition. J. Pharm. Biomed. Anal. 2011, 56, 16. doi:10.1016/J.JPBA.2011.04.017
33. I. Vaz-Moreira, O. C. Nunes, C. M. Manaia, Diversity and antibiotic resistance in Pseudomonas spp. from drinking water. Sci. Total Environ. 2012, 426, 366. doi:10.1016/J.SCITOTENV.2012.03.046
34. N. J. Palleroni, The Pseudomonas story. Environ. Microbiol. 2010, 12, 1377. doi:10.1111/J.1462-2920.2009.02041.X
35. G. Neumann, Y. Veeranagouda, T. B. Karegoudar, O. Sahin, I. Mausezahl, N. Kabelitz, U. Kappelmeyer, H. J. Heipieper, Cells of Pseudomonas putida and Enterobacter sp. adapt to toxic organic compounds by increasing their size. Extremophiles 2005, 9, 163. doi:10.1007/S00792-005-0431-X
36. M. Vodovnik, M. Bistan, M. Zorec, R. M. Logar, Membrane changes associated with exposure of Pseudomonas putida to selected environmental pollutants and their possible roles in toxicity. Acta Chim. Slov. 2012, 59, 83.
37. OECD Guideline for testing of chemicals: In vitro 3T3 NRU phototoxicity test 2004 (Organisation of Economic Cooperation and Development: Paris).
38. K. D. Han, K. M. Bark, E. P. Heo, J. K. Lee, J. S. Kang, T. H. Kim, Increased phototoxicity of hydrochlorothiazide by photodegradation. Photodermatol. Photo. 2000, 16, 121. doi:10.1034/J.1600-0781.2000. D01-17.X
39. A. A. Chételat, S. Albertini, E. Gocke, The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). Mutagenesis 1996, 11, 497. doi:10.1093/MUTAGE/11.5.497
40. K. Yu, B. Li, T. Zhang, Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography- tandem mass spectrometry without SPE pre-concentration. Anal. Chim. Acta 2012, 738, 59. doi:10.1016/J.ACA.2012.05.057
41. J. Fick, H. Soderstrom, R. H. Lindberg, C. Phan, M. Tysklind, D. G. J. Larsson, Contamination of surface, ground, and drinking water from pharmaceutical production. Environ. Toxicol. Chem. 2009, 28, 2522. doi:10.1897/09-073.1
42. J. Kosonen, L. Kronberg, The occurrence of antihistamines in sewage waters and in recipient rivers. Environ. Sci. Pollut. R. 2009, 16, 555. doi:10.1007/S11356-009-0144-2
43. B. Kasprzyk-Hordern, R. M. Dinsdale, A. J. Guwy, The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43, 363. doi:10.1016/J.WATRES.2008.10.047
44. K. Choi, Y. Kim, J. Park, C. K. Park, M. Kim, H. S. Kim, P. Kim, Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci. Total Environ. 2008, 405, 120. doi:10.1016/J.SCITOTENV.2008.06.038
45. D. W. Kolpin, E. T. Furlong, M. T. Meyer, E. M. Thurman, S. D. Zaugg, L. B. Barber, H. T. Buxton, Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202. doi:10.1021/ES011055J
46. J. W. Kim, H. S. Jang, J. G. Kim, H. Ishibashi, M. Hirano, K. Nasu, N. Ichikawa, Y. Takao, R. Shinohara, K. Arizono, Occurrence of pharmaceutical and personal care products (PPCPs. in surface water from Mankyung River, South Korea. J. Health Sci. 2009, 55, 249. doi:10.1248/JHS.55.249
47. H. Lindberg, J. Fick, M. Tysklind, Screening of antimycotics in Swedish sewage treatment plants - waters and sludge. Water Res. 2010, 44, 649. doi:10.1016/J.WATRES.2009.10.034
48. M. Kahle, I. J. Buerge, A. Hauser, M. D. Mueller, T. Poiger, Azole fungicides: occurrence and fate in wastewater and surface waters. Environ. Sci. Technol. 2008, 42, 7193. doi:10.1021/ES8009309
49. D. Calamari, E. Zuccato, S. Castiglioni, R. Bagnati, R. Fanelli, Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ. Sci. Technol. 2003, 37, 1241. doi:10.1021/ES020158E
50. E. Zuccato, S. Castiglioni, R. Fanelli, G. Reitano, R. Bagnati, C. Chiabrando, F. Pomati, C. Rossetti, D. Calamari, Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ. Sci. Pollut. R. 2006, 13, 15. doi:10.1065/ESPR2006.01.004
51. T. Heberer, Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266, 175. doi:10.1016/S0022-1694(02) 00165-8
52. M. J. Benotti, R. A. Trenholm, B. J. Vanderford, J. C. Holady, B. D. Stanford, S. A. Snyder, Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ. Sci. Technol. 2009, 43, 597. doi:10.1021/ES801845A
53. G. M. Bruce, R. C. Pleus, S. A. Snyder, Toxicological relevance of pharmaceuticals in drinking water. Environ. Sci. Technol. 2010, 44, 5619. doi:10.1021/ES1004895
54. D. Hummel, D. Loeffler, G. Fink, T. A. Ternes, Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ. Sci. Technol. 2006, 40, 7321. doi:10.1021/ES061740W
55. B. Morasch, F. Bonvin, H. Reiser, D. Grandjean, L. F. de Alencastro, C. Perazzolo, N. Chevre, T. Kohn, Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part II: micropollutant removal between wastewater and raw drinking water. Environ. Toxicol. Chem. 2010, 2259, 1658.
56. Y. C. Guo, S. W. Krasner, Occurrence of primidone, carbamazepine, caffeine, and precursors for n-nitrosodimethylamine in drinking water sources impacted by wastewater. J. Am. Water Resour. Assoc. 2009, 45, 58. doi:10.1111/J.1752-1688.2008.00289.X
57. S. Castiglioni, R. Fanelli, D. Calamari, R. Bagnati, E. Zuccato, Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy. Regul. Toxicol. Pharmacol. 2004, 39, 25. doi:10.1016/J.YRTPH.2003.10.002
58. J. Fick, R. H. Lindberg, L. Kai, E. Brorstoem-Lundén, Results from the Swedish National Screening programme 2010 2011 (IVL Swedish Environmental Research Institute: Stockholm, Sweden).
59. H. D. Zhou, C. Y. Wu, X. Huang, M. J. Gao, X. H. Wen, H. Tsuno, H. Tanaka, Occurrence of selected pharmaceuticals and caffeine in sewage treatment plants and receiving rivers in Beijing, China. Water Environ. Res. 2010, 82, 2239. doi:10.2175/106143010X12681059116653
60. T. Okuda, Y. Kobayashi, R. Nagao, N. Yamashita, H. Tanaka, S. Tanaka, S. Fujii, C. Konishi, I. Houwa, Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. Water Sci. Technol. 2008, 57, 65. doi:10.2166/WST.2008.822